Elitza S. Theel, Ph.D., D(ABMM)
Mayo Clinic
Elitza (Elli) S. Theel, Ph.D., D(ABMM), is director of the Infectious Diseases Serology Laboratory and co-director of the Vector-Borne Diseases Service Line at Mayo Clinic in Rochester, Minn. She is associate professor of laboratory medicine and pathology at Mayo Clinic, and is the program director for the Clinical Microbiology CPEP progam.
Theel received her Ph.D. in medical microbiology and immunology at the University of Wisconsin-Madison, and subsequently completed a clinical microbiology fellowship at Mayo Clinic. She is certified by the American Board of Medical Microbiology. She is a member of the editorial board for multiple journals, including the and Clinical Infectious Diseases. Theel serves on the CAP Microbiology Resource Committee and the APHL/CDC working group for standardization of reporting language for Lyme disease serologic testing.
Her research interests revolve around the evaluation and development of serologic assays for vector-borne diseases and fungal pathogens. Finally, she also spearheads a philanthropic, international laboratory outreach initiative in Belize, focused on increasing the in-country testing capacity for vector-borne diseases, establishing seroprevalence rates for these pathogens and enhancing the quality assurance/quality control practices in clinical laboratories throughout the country.
Theel received her Ph.D. in medical microbiology and immunology at the University of Wisconsin-Madison, and subsequently completed a clinical microbiology fellowship at Mayo Clinic. She is certified by the American Board of Medical Microbiology. She is a member of the editorial board for multiple journals, including the and Clinical Infectious Diseases. Theel serves on the CAP Microbiology Resource Committee and the APHL/CDC working group for standardization of reporting language for Lyme disease serologic testing.
Her research interests revolve around the evaluation and development of serologic assays for vector-borne diseases and fungal pathogens. Finally, she also spearheads a philanthropic, international laboratory outreach initiative in Belize, focused on increasing the in-country testing capacity for vector-borne diseases, establishing seroprevalence rates for these pathogens and enhancing the quality assurance/quality control practices in clinical laboratories throughout the country.